Tiocianát (Hungarian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tiocianát" in Hungarian language version.

refsWebsite

Global rank Hungarian rank

13nih.gov

4^th place

11^th place

5doi.org

2^nd place

8^th place

2archive.org

6^th place

14^th place

archive.org

White WE, Pruitt KM, Mansson-Rahemtulla B (1983. February). „Peroxidase-thiocyanate-peroxide antibacterial system does not damage DNA”. Antimicrob. Agents Chemother. 23 (2), 267–72. o. PMID 6340603. PMC 186035.
Thomas EL, Aune TM (1978. May). „Lactoperoxidase, peroxide, thiocyanate antimicrobial system: correlation of sulfhydryl oxidation with antimicrobial action”. Infect. Immun. 20 (2), 456–63. o. PMID 352945. PMC 421877.

doi.org

dx.doi.org

Conner GE, Wijkstrom-Frei C, Randell SH, Fernandez VE, Salathe M (2007. January). „The lactoperoxidase system links anion transport to host defense in cystic fibrosis”. FEBS Lett. 581 (2), 271–8. o. DOI:10.1016/j.febslet.2006.12.025. PMID 17204267. PMC 1851694.
Childers M, Eckel G, Himmel A, Caldwell J (2007). „A new model of cystic fibrosis pathology: lack of transport of glutathione and its thiocyanate conjugates”. Med. Hypotheses 68 (1), 101–12. o. DOI:10.1016/j.mehy.2006.06.020. PMID 16934416.
Minarowski Ł, Sands D, Minarowska A, Karwowska A, Sulewska A, Gacko M, Chyczewska E (2008). „Thiocyanate concentration in saliva of cystic fibrosis patients”. Folia Histochem. Cytobiol. 46 (2), 245–6. o. DOI:10.2478/v10042-008-0037-0. PMID 18519245.
Moskwa P, Lorentzen D, Excoffon KJ, Zabner J, McCray PB, Nauseef WM, Dupuy C, Bánfi B (2007. January). „A novel host defense system of airways is defective in cystic fibrosis”. Am. J. Respir. Crit. Care Med. 175 (2), 174–83. o. DOI:10.1164/rccm.200607-1029OC. PMID 17082494. PMC 2720149.
Xu Y, Szép S, Lu Z (2009. December). „The antioxidant role of thiocyanate in the pathogenesis of cystic fibrosis and other inflammation-related diseases”. Proc. Natl. Acad. Sci. U.S.A. 106 (48), 20515–9. o. DOI:10.1073/pnas.0911412106. PMID 19918082. PMC 2777967.

nih.gov

pubmed.ncbi.nlm.nih.gov

Pedemonte N, Caci E, Sondo E, Caputo A, Rhoden K, Pfeffer U, Di Candia M, Bandettini R, Ravazzolo R, Zegarra-Moran O, Galietta LJ (2007. April). „Thiocyanate transport in resting and IL-4-stimulated human bronchial epithelial cells: role of pendrin and anion channels”. J. Immunol. 178 (8), 5144–53. o. PMID 17404297.
Conner GE, Wijkstrom-Frei C, Randell SH, Fernandez VE, Salathe M (2007. January). „The lactoperoxidase system links anion transport to host defense in cystic fibrosis”. FEBS Lett. 581 (2), 271–8. o. DOI:10.1016/j.febslet.2006.12.025. PMID 17204267. PMC 1851694.
White WE, Pruitt KM, Mansson-Rahemtulla B (1983. February). „Peroxidase-thiocyanate-peroxide antibacterial system does not damage DNA”. Antimicrob. Agents Chemother. 23 (2), 267–72. o. PMID 6340603. PMC 186035.
Thomas EL, Aune TM (1978. May). „Lactoperoxidase, peroxide, thiocyanate antimicrobial system: correlation of sulfhydryl oxidation with antimicrobial action”. Infect. Immun. 20 (2), 456–63. o. PMID 352945. PMC 421877.
Childers M, Eckel G, Himmel A, Caldwell J (2007). „A new model of cystic fibrosis pathology: lack of transport of glutathione and its thiocyanate conjugates”. Med. Hypotheses 68 (1), 101–12. o. DOI:10.1016/j.mehy.2006.06.020. PMID 16934416.
Minarowski Ł, Sands D, Minarowska A, Karwowska A, Sulewska A, Gacko M, Chyczewska E (2008). „Thiocyanate concentration in saliva of cystic fibrosis patients”. Folia Histochem. Cytobiol. 46 (2), 245–6. o. DOI:10.2478/v10042-008-0037-0. PMID 18519245.
Moskwa P, Lorentzen D, Excoffon KJ, Zabner J, McCray PB, Nauseef WM, Dupuy C, Bánfi B (2007. January). „A novel host defense system of airways is defective in cystic fibrosis”. Am. J. Respir. Crit. Care Med. 175 (2), 174–83. o. DOI:10.1164/rccm.200607-1029OC. PMID 17082494. PMC 2720149.
Xu Y, Szép S, Lu Z (2009. December). „The antioxidant role of thiocyanate in the pathogenesis of cystic fibrosis and other inflammation-related diseases”. Proc. Natl. Acad. Sci. U.S.A. 106 (48), 20515–9. o. DOI:10.1073/pnas.0911412106. PMID 19918082. PMC 2777967.

ncbi.nlm.nih.gov

Conner GE, Wijkstrom-Frei C, Randell SH, Fernandez VE, Salathe M (2007. January). „The lactoperoxidase system links anion transport to host defense in cystic fibrosis”. FEBS Lett. 581 (2), 271–8. o. DOI:10.1016/j.febslet.2006.12.025. PMID 17204267. PMC 1851694.
White WE, Pruitt KM, Mansson-Rahemtulla B (1983. February). „Peroxidase-thiocyanate-peroxide antibacterial system does not damage DNA”. Antimicrob. Agents Chemother. 23 (2), 267–72. o. PMID 6340603. PMC 186035.
Thomas EL, Aune TM (1978. May). „Lactoperoxidase, peroxide, thiocyanate antimicrobial system: correlation of sulfhydryl oxidation with antimicrobial action”. Infect. Immun. 20 (2), 456–63. o. PMID 352945. PMC 421877.
Moskwa P, Lorentzen D, Excoffon KJ, Zabner J, McCray PB, Nauseef WM, Dupuy C, Bánfi B (2007. January). „A novel host defense system of airways is defective in cystic fibrosis”. Am. J. Respir. Crit. Care Med. 175 (2), 174–83. o. DOI:10.1164/rccm.200607-1029OC. PMID 17082494. PMC 2720149.
Xu Y, Szép S, Lu Z (2009. December). „The antioxidant role of thiocyanate in the pathogenesis of cystic fibrosis and other inflammation-related diseases”. Proc. Natl. Acad. Sci. U.S.A. 106 (48), 20515–9. o. DOI:10.1073/pnas.0911412106. PMID 19918082. PMC 2777967.